A_Zeneca

· Mayo Clinic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A_Zeneca, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Myeloperoxidase (MPO) Inhibitor A_Zeneca for Heart Failure With Preserved Ejection Fraction (HFpEF) [Phase 1, Phase 2]

See pricing